Quick links

Secure login

Secure file transfer protocol

Register or renew user


Contact us

Trouble logging in? Forgot password? We can help!

philavax@phila.gov

215-685-6784

215-238-6944


Register a clinic

Fill out both forms, then either email or fax them to us at the contact above.

Clinic registration form
Enity confidentiality form

On behalf of patients

Patient update request

Looking for something else?

PhilaVax program info
Flat file reporting guide
More PhilaVax resources

Urgent Update on COVID-19 Program The Philadelphia Department of Public Health's (PDPH) COVID-19 program is expected to end this Tuesday, 9/12 when full commercialization begins. Any COVID-19 vaccine in your inventory received from PDPH will no longer be authorized for use. All remaining inventory must be reported as wastage and...

Private COVID-19 Vaccine Procurement  Commercialization of COVID-19 vaccines is occurring next week. VFC Providers are required to match vaccines on the private side. We have created an FAQ to assist providers through this transition.  Take these steps now to plan which COVID-19 vaccines you will purchase privately:  Review the anticipated...

[vc_row][vc_column][vc_column_text] New Vaccine Product Available Through VFC: Prevnar 20 On June 27, 2023, the CDC approved Prevnar 20 (PCV20) for use in pediatric patients. Beginning September 6, 2023, this Prevnar 20 is available to order for your VFC eligible patients. The Prevnar 13 (PCV13) is no longer...

Recap: RSV Immunization in Outpatient Settings Thank you to those who attended the RSV townhall for nirsevimab (Beyfortus) immunization in outpatient settings on Tuesday, August 29! In case you missed it, please review important information below:  PDPH townhall presentation slides PDPH townhall meeting recording Nirsevimab FAQ Nirsevimab planning checklist Nirsevimab will...

Integrating RSV Immunization into EHR Systems RSV immunization will be available to order through the Vaccines for Children (VFC) program this fall. This newly approved monoclonal antibody, nirsevimab (Beyfortus), will be used to protect newborns and infants born during or entering their first RSV season.As your facility will likely...

Recap: RSV Immunization in Inpatient Settings Thank you to those who attended the RSV townhall for nirsevimab (Beyfortus) immunization in inpatient settings on Friday, August 24! In case you missed it, please review important information below: PDPH townhall presentation slides PDPH townhall meeting recording Nirsevimab FAQ Nirsevimab planning checklist Nirsevimab will...

Mpox Vaccine: Labor Day Schedule The City of Philadelphia will be closed on Monday, September 4th in observance of Labor Day. Mpox orders are due by 5pm on Tuesday, September 5th during this week. Deliveries will continue as normal.  Place an order ...

RSV Townhall to Discuss Nirsevimab Come learn about the newly approved monoclonal antibody, nirsevimab (Beyfortus), to prevent RSV in neonates and young infants at a townhall hosted by the Philadelphia Immunization Program.  The townhall will take place over Zoom on Tuesday August 29 at 12pm. Nirsevimab will be...

VFC & VFAAR Flu Ordering Will Open 8/28/23 VFC & VFAAR providers can order flu for the 2023-24 season starting Monday, 8/28/23. Make sure your site is ready! Account for any unused 2022-23 VFC/VFAAR flu vaccine still at your site using PhilaVax: Process a return for the unopened...

Bridge Access Program Pre-Enrollment is Live Please complete the pre-enrollment survey below. This survey will provide our team with key information to determine if your site is eligible for enrollment.   The survey does not generate a confirmation email automatically. Our team will review your responses and reach...